These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16787680)

  • 1. Nitric oxide as treatment for an emerging epidemic of obesity-related glomerulopathy.
    Ahmed MH; Khalil A; Osman MM
    Diabetes Res Clin Pract; 2006 Nov; 74(2):207-8. PubMed ID: 16787680
    [No Abstract]   [Full Text] [Related]  

  • 2. [Influence of obesity in children on kidney].
    Roszkowska-Blaim M
    Przegl Lek; 2006; 63 Suppl 3():25-8. PubMed ID: 16898481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Podocyte lesions in patients with obesity-related glomerulopathy.
    Chen HM; Liu ZH; Zeng CH; Li SJ; Wang QW; Li LS
    Am J Kidney Dis; 2006 Nov; 48(5):772-9. PubMed ID: 17059996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obesity and kidney disease: a big dilemma.
    Kramer H; Luke A
    Curr Opin Nephrol Hypertens; 2007 May; 16(3):237-41. PubMed ID: 17420667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity-related glomerulopathy: another nail in the coffin of the epidemic of end-stage renal disease.
    Ahmed MH; Khalil AA
    J Clin Pathol; 2007 May; 60(5):582. PubMed ID: 17513523
    [No Abstract]   [Full Text] [Related]  

  • 7. Chloroquine-induced nitric oxide: new treatment for an emerging epidemic of obesity-related glomerulopathy.
    Osman MM; Khalil A; Ahmed MH
    Diabetes Technol Ther; 2006 Dec; 8(6):691-2. PubMed ID: 17109602
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of septic renal injury by alkaline phosphatase: an emperor with new clothes.
    Groeneveld AB; Vervloet MG
    Crit Care Med; 2009 Feb; 37(2):740-1. PubMed ID: 19325362
    [No Abstract]   [Full Text] [Related]  

  • 9. Kidney damage after renal ablation is worsened in endothelial nitric oxide synthase -/- mice and improved by combined administration of L-arginine and antioxidants.
    Mendoza MG; Castillo-Henkel C; Medina-Santillan R; Jarillo Luna RA; Robles HV; Romo E; Rios A; Escalante B
    Nephrology (Carlton); 2008 Jun; 13(3):218-27. PubMed ID: 18315704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
    Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
    J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A new treatment of renal disease in AA amyloidosis...and not only that?].
    Pani A
    G Ital Nefrol; 2008; 25(1):12. PubMed ID: 18264913
    [No Abstract]   [Full Text] [Related]  

  • 13. Obesity, proteinuria and progression of renal failure.
    Praga M; Morales E
    Curr Opin Nephrol Hypertens; 2006 Sep; 15(5):481-6. PubMed ID: 16914959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity-related glomerulopathy.
    Tran HA
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6358. PubMed ID: 15579804
    [No Abstract]   [Full Text] [Related]  

  • 15. Obesity and kidney disease: Beyond the hyperfiltration.
    Mascali A; Franzese O; Nisticò S; Campia U; Lauro D; Cardillo C; Di Daniele N; Tesauro M
    Int J Immunopathol Pharmacol; 2016 Sep; 29(3):354-63. PubMed ID: 27044633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet nitric oxide production and IR: relation with obesity and hypertriglyceridemia.
    Vignini A; Nanetti L; Moroni C; Testa R; Sirolla C; Marra M; Cenerelli S; Gregori A; Fumelli D; Olivieri F; Mazzanti L; Rabini RA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):553-8. PubMed ID: 18155481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity, insulin resistance and kidney disease risk: insights into the relationship.
    Sarafidis PA
    Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):450-6. PubMed ID: 18695384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of obesity and chronic kidney disease.
    Ross WR; McGill JB
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):325-35. PubMed ID: 17045219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelial-derived nitric oxide in hypertension and renal disease.
    Marin E; Sessa WC
    Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):105-10. PubMed ID: 17293684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.